75 results
SC TO-C
EX-10.1
VECT
VectivBio Holding AG
22 May 23
Information about tender offer
4:26pm
) payments made in respect of hedging obligations or other derivative instruments entered into for the purpose of hedging interest rate risk, (E) cash … and charges owed with respect to letters of credit and bankers’ acceptance financing and net costs under hedging agreements, plus
(b) non-cash
8-K
EX-10.1
8n05k4
22 May 23
Entry into a Material Definitive Agreement
4:25pm
8-K
EX-99.1
y37 vv5xlt6ssezyjyk9
3 Nov 22
Ironwood Pharmaceuticals Reports Strong Third Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance
7:00am
8-K
EX-99.1
f36spj8r
4 Aug 22
Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand
7:06am
8-K
EX-99.1
mtj9 8tv1s
5 May 22
Ironwood Pharmaceuticals Reports First Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance
7:07am